Add to ORKGThe effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cell
Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-ce...
The quality of Ag-specific CD8+ T cell responses is central to immune efficacy in infectious and mal...
Background: Tumors can be targeted by the adoptive transfer of chimeric antigen receptor (CAR) redir...
Background Adoptive cell therapy with ex vivo expanded autologous antitumor cytotoxic T lymphocytes ...
Artificial antigen-presenting cells are expected to stimulate the expansion and acquisition of optim...
Effective adoptive T cell therapy requires the _ex vivo_ generation of functional T lymphocytes with...
Adoptive immunotherapy has great potential to treat a wide variety of diseases, including cancer and...
Background and purpose: In recent years, immunotherapy using chimeric antigen receptor T cells (CAR ...
Abstract Background Development of a standardized platform for the rapid expansion of tumor-infiltra...
Background: Using in vivo mouse models, the mechanisms of CD4+ T cell help have been intensively inv...
[Extract] In times of limited material, expansion of T cells in vitro has become a standard practice...
The adoptive transfer of effector T cells combined with lymphodepletion has demonstrated promising a...
International audienceThe quality of Ag-specific CD8+ T cell responses is central to immune efficacy...
Purpose: Genetically engineered T cells are powerful anticancer treatments but are limited by safety...
Adoptive cell therapy involves the infusion of tumor-reactive T cells into patients with cancer to p...
Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-ce...
The quality of Ag-specific CD8+ T cell responses is central to immune efficacy in infectious and mal...
Background: Tumors can be targeted by the adoptive transfer of chimeric antigen receptor (CAR) redir...
Background Adoptive cell therapy with ex vivo expanded autologous antitumor cytotoxic T lymphocytes ...
Artificial antigen-presenting cells are expected to stimulate the expansion and acquisition of optim...
Effective adoptive T cell therapy requires the _ex vivo_ generation of functional T lymphocytes with...
Adoptive immunotherapy has great potential to treat a wide variety of diseases, including cancer and...
Background and purpose: In recent years, immunotherapy using chimeric antigen receptor T cells (CAR ...
Abstract Background Development of a standardized platform for the rapid expansion of tumor-infiltra...
Background: Using in vivo mouse models, the mechanisms of CD4+ T cell help have been intensively inv...
[Extract] In times of limited material, expansion of T cells in vitro has become a standard practice...
The adoptive transfer of effector T cells combined with lymphodepletion has demonstrated promising a...
International audienceThe quality of Ag-specific CD8+ T cell responses is central to immune efficacy...
Purpose: Genetically engineered T cells are powerful anticancer treatments but are limited by safety...
Adoptive cell therapy involves the infusion of tumor-reactive T cells into patients with cancer to p...
Adoptive T-cell therapies have shown exceptional promise in the treatment of cancer, especially B-ce...
The quality of Ag-specific CD8+ T cell responses is central to immune efficacy in infectious and mal...
Background: Tumors can be targeted by the adoptive transfer of chimeric antigen receptor (CAR) redir...